Bioadhesive drug formulations for oral transmucosal delivery

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8252329
APP PUB NO 20080166404A1
SERIAL NO

11825251

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ACELRX PHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hamel, Larry Mountain View, US 19 907
Palmer, Pamela San Francisco, US 35 1387
Poutiatine, Andrew I San Anselmo, US 39 1871
Schreck, Thomas Portola Valley, US 29 1714
Tzannis, Stelios Newark, US 39 1491

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 28, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00